Root (ROOT) had the highest return in Q1 2024 by a US stock with a market cap of $1B+, returning 486.2%.

ASSET	QUARTER	% RETURN
Root (ROOT)	Q1 2024	486.18%
Dave (DAVE)	Q1 2024	355.71%
Viking Therapeutics (VKTX)	Q1 2024	342.53%
Sezzle Inc Common Stock (SEZL)	Q1 2024	302.33%
Super Micro Computer (SMCI)	Q1 2024	260.73%
Janux Therapeutics (JANX)	Q1 2024	252.53%
Trump Media & Technology (DJT)	Q1 2024	251.25%
GeneDx (WGS)	Q1 2024	238.15%
WM Technology (MAPSW)	Q1 2024	225%
Arcutis Biotherapeutics (ARQT)	Q1 2024	212.62%
Vera Therapeutics (VERA)	Q1 2024	183.68%
Avidity Biosciences (RNA)	Q1 2024	182.93%
SoundHound AI (SOUN)	Q1 2024	176.53%
Praxis Precision Medicines (PRAX)	Q1 2024	174.37%
MicroStrategy (MSTR)	Q1 2024	146.15%
Apogee Therapeutics, Inc Common Stock (APGE)	Q1 2024	142.08%
Intuitive Machines (LUNR)	Q1 2024	137.64%
Mesoblast (MESO)	Q1 2024	131.94%
D-Wave Quantum (QBTS)	Q1 2024	131.82%
Sweetgreen (SG)	Q1 2024	127.98%
Dyne Therapeutics (DYN)	Q1 2024	118.05%
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS)	Q1 2024	111.16%
Flex (FLEX)	Q1 2024	110.19%
Ocular Therapeutix (OCUL)	Q1 2024	106.82%
Establishment Labs (ESTA)	Q1 2024	99.69%